FAST, Fellows and CARB-X Update November 2019

 FAST & Fellows Round-Up

• Raydiant Oximetry (FAST Spring ‘17) raised a $5.6 million Series A fund Read More
• Inflammatix (FAST Fall ‘17) inked a contract worth up to $72M with BARDA to further develop and commercialize its sample-to-answer HostDx molecular testing system Read More
• Paragon Genomics (FAST Spring ‘16) introduces two new products — CleanPlex® CFTR Panel for cystic fibrosis and CleanPlex Fusion Detection Methods for the diagnostic and prognostic assessment of cancer tumor progression Read More
• Shasqi (FAST Spring ’16) announced the completion of a $10 million Series A financing Read More
• Xcell Biosciences (FAST Fall ’13) CEO Brian Feth took first place at the World Alliance Forum Healthcare Game Changers Startup Pitch competition, one of five companies to pitch in front of 300 investors and business executives from the U.S. and Japan.

CARB-X News

• CARB-X funds BioVersys to support the development of first-in-class anti-virulence small molecule drugs designed to disarm bacteria Read More
• CARB-X funds Techulon to support the development of innovative nano therapeutics capable of killing drug-resistant bacteria by precisely targeting essential genes Read More